Literature DB >> 27373107

PRESERVATIVES FROM THE EYE DROPS AND THE OCULAR SURFACE.

Mihaela Cristina Coroi, Simona Bungau, Mirela Tit.   

Abstract

The use of preservatives in eye drops (eyewashes) has known glory at the beginning, but the side effects that they have on the ocular surface have led to a decrease of their popularity. Lachrymal film dysfunction, ocular hyperemia, dotted keratitis or toxic keratopathy were reported and analyzed in terms of pathophysiological mechanism of the role played by preservatives in ophthalmic drops (eyewashes). This article reviews the most common preservatives and the existing alternatives for the maintenance of the eye sterile drops. Keywords: preservatives, eye drops, ocular surface

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 27373107      PMCID： PMC5729814     

Source DB:  PubMed          Journal:  Rom J Ophthalmol        ISSN： 2457-4325


  21 in total

Review 1.  Ocular tolerance of preservatives and alternatives.

Authors:  Pascal Furrer; Joachim M Mayer; Robert Gurny
Journal:  Eur J Pharm Biopharm       Date:  2002-05       Impact factor: 5.571

2.  Anatomy of a regimen: consideration of multipurpose solutions during non-compliant use.

Authors:  Ruth A Rosenthal; Cindy L Henry; Ralph P Stone; Barry A Schlech
Journal:  Cont Lens Anterior Eye       Date:  2003-03       Impact factor: 3.077

3.  [Ophthalmic preservatives and preparations: reality and perspectives].

Authors:  H Chibret
Journal:  Ann Pharm Fr       Date:  1997

4.  Chronic topical eye preservative-free beta-blocker therapy effect on the ocular surface in glaucomatous patients.

Authors:  P Campagna; A Macri; M Rolando; G Calabria
Journal:  Acta Ophthalmol Scand Suppl       Date:  1997

5.  Survival of contaminating bacteria in over-the-counter artificial tears.

Authors:  M G Harris; A Gee; R Kusumoto; H Lee
Journal:  J Am Optom Assoc       Date:  1996-11

6.  Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1: an experimental study.

Authors:  Antoine Labbé; Aude Pauly; Hong Liang; Françoise Brignole-Baudouin; Chantal Martin; Jean-Michel Warnet; Christophe Baudouin
Journal:  J Ocul Pharmacol Ther       Date:  2006-08       Impact factor: 2.671

7.  The effect of preservatives and antiglaucomatous medication on the histopathology of the conjunctiva.

Authors:  H Mietz; U Niesen; G K Krieglstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-09       Impact factor: 3.117

8.  Cytotoxicity and effects on metabolism of contact lens care solutions on human corneal epithelium cells.

Authors:  Camus K M Choy; Pauline Cho; Maureen V Boost
Journal:  Clin Exp Optom       Date:  2012-01-11       Impact factor: 2.742

9.  Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells.

Authors:  M De Saint Jean; F Brignole; A F Bringuier; A Bauchet; G Feldmann; C Baudouin
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-03       Impact factor: 4.799

10.  [Effect of preservatives on the conjunctiva: a comparative study of beta-blocker eye drops with and without preservatives in glaucoma patients].

Authors:  P J Pisella; E Lala; V Parier; F Brignole; C Baudouin
Journal:  J Fr Ophtalmol       Date:  2003-09       Impact factor: 0.818
View more
  8 in total

Review 1.  A Review of Management Strategies for Nociceptive and Neuropathic Ocular Surface Pain.

Authors:  Harrison Dermer; Daniella Lent-Schochet; Despoina Theotoka; Christian Paba; Abdullah A Cheema; Ryan S Kim; Anat Galor
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

Review 2.  Bilastine 10 and 20 mg in paediatric and adult patients: an updated practical approach to treatment decisions.

Authors:  Amalia Leceta; Aintzane García; Ander Sologuren; Cristina Campo
Journal:  Drugs Context       Date:  2021-08-10

Review 3.  Dexamethasone 0.4mg Sustained-Release Intracanalicular Insert in the Management of Ocular Inflammation and Pain Following Ophthalmic Surgery: Design, Development and Place in Therapy.

Authors:  Cassandra C Brooks; Sayena Jabbehdari; Preeya K Gupta
Journal:  Clin Ophthalmol       Date:  2020-01-13

4.  The in vitro efficacy of eye drops containing a bacteriophage solution specific for Staphylococcus spp. isolated from dogs with bacterial conjunctivitis.

Authors:  Renata Urban-Chmiel; Ireneusz Balicki; Katarzyna Świąder; Anna Nowaczek; Ewelina Pyzik; Dagmara Stępień-Pyśniak; Agnieszka Marek; Andrzej Puchalski; Andrzej Wernicki; Ewa Poleszak; Marta Dec
Journal:  Ir Vet J       Date:  2020-11-04       Impact factor: 2.146

5.  Reduction of Artificial Tears and Use of Adjunctive Dry Eye Therapies After Lifitegrast Treatment: Evidence from Clinical and Real-World Studies.

Authors:  Kelly K Nichols; Eric D Donnenfeld; Charis Lau; Annie Syntosi; Paul Karpecki; John A Hovanesian
Journal:  Clin Ophthalmol       Date:  2022-03-25

Review 6.  Ocular benzalkonium chloride exposure: problems and solutions.

Authors:  Michael H Goldstein; Fabiana Q Silva; Nysha Blender; Trung Tran; Srilatha Vantipalli
Journal:  Eye (Lond)       Date:  2021-07-14       Impact factor: 4.456

Review 7.  Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents.

Authors:  Eliana B Souto; João Dias-Ferreira; Ana López-Machado; Miren Ettcheto; Amanda Cano; Antonio Camins Espuny; Marta Espina; Maria Luisa Garcia; Elena Sánchez-López
Journal:  Pharmaceutics       Date:  2019-09-06       Impact factor: 6.321

Review 8.  Targeted Drug Delivery Systems for the Treatment of Glaucoma: Most Advanced Systems Review.

Authors:  Olga Cegielska; Paweł Sajkiewicz
Journal:  Polymers (Basel)       Date:  2019-10-24       Impact factor: 4.329
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.